Bibliography
- Chang HC, Samaniego F, Nair BC, et al. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 1997;11:1421-31
- Liu Y, Jones M, Hingtgen CM. Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 2000;6:1380-7
- Abes S, Richard JP, Thierry A, et al. Tat-derived cell-penetrating peptides: discovery, mechanism of cell uptake, and applications to the delivery of oligonucleotides. In: Langel Ü, editor, Handbook of Cell-penetrating Peptides. CRC Press, Boca Raton, 2007. p. 29-42
- Fawell S, Seery J, Daikh Y, et al. Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 1994;91:664-8
- Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 1997;272:16010-17
- Futaki S, Suzuki T, Ohashi W, et al. Arginine-rich peptides: An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001;76:5836-40
- Pooga M, HÄllbrink M, Zorko M, et al. Arginine-rich peptides: An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001;76:5836-40
- Soomets U, Lindgren M, Gallet X, et al. Deletion analogs of transportan. Biochim Biophys Acta 2000;467:165-76
- Jones S, Martel C, Belzacq-Casagrande AS, et al. Mitoparan and target-selective chimeric analogues: Membrane translocation and intracellular redistribution induces mitochondrial apoptosis. Biochim Biophys Acta 2008;783:849-63
- Oehlke J, Wiesner B, Bienert M. Model amphipathic peptides. In: Langel Ü, editor, Handbook of cell-penetrating peptides. CRC Press, Boca Raton, 2007;pp. 43-60
- Dupont E, Prochiantz A, Joliot A. Penetratins. In: Langel Ü, editor, Handbook of cell-penetrating peptides. CRC Press, Boca Raton, 2007. p. 5-28
- Hällbrink M, Kilk K, Elmquist A, et al. Prediction of Cell-Penetrating Peptides. Int J Pept Res Ther 2005;11:249-59
- Hansen M, Kilk K, Langel Ü. Predicting cell-penetrating peptides. Adv Drug Deliver Rev 2008;60:572-9
- Howl J, Jones S. Proteomimetic cell penetrating peptides. Int J Pept Res Ther 2008;14:359-66
- Wagstaff KM, Jans DA. Protein transduction: Cell penetrating peptides and their therapeutic applications. Curr Med Chem 2006;13:1371-87
- Wadia JS, Dowdy SF. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv Drug Deliver Rev 2005;57:579-96
- Abes S, Turner JT, Ivanova GD, et al. Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide. Nucleic Acids Res 2007;35:4495-502
- Coupade C, Fittipaldi A, Chagnas V, et al. Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. Biochem J 2005;390:407-18
- McClorey G, Moulton HM, Iversen PL, et al. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Ther 2006;13:1373-81
- Morris MC, Depollier J, Mery J, et al. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 2001;19:1173-6
- Meade BR, Dowdy SF. Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv Drug Deliver Rev 2008;60:530-6
- Torchlin VP. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Drug Deliver Rev 2008;60:548-58
- Chan WC, White PD. Fmoc solid phase peptide synthesis. A practical approach. Oxford University Press, New York, 2000
- Chorev M, Goodman M. Recent developments in retro peptides and proteins – an ongoing topochemical explanation. Trends Biotechnol 1995;13:438-45
- Chorev M, Goodman M. A dozen years of retro-inverso peptidomimetics. Acc. Chem Res 1993;26:266-73
- Bonny C, Oberson A, Negri S, et al. Cell-permeable peptide inhibitors of JNK. Novel blockers of β-cell death. Diabetes 2001;50:77-82
- Repici M, Centeno C, Tomasi S, et al. Time-course of c-Jun and N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 and c-Jun and caspase-3 activation. Neurosci 2007;150:40-9
- Snyder EL, Meade BR, Saenz CC, et al. Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide. PLoS Biol 2004;2:186-93
- Schorderet DF, Allèves V, Canola K, et al. D-TAT transporter as an ocular peptide delivery system. Clin Exp Ophthalmol 2005;33:628-35
- Wan L, Zhang X, Gunaseelan S, et al. Novel multi-component nanopharmaceutical derived from poly(ethylene)glycol, retro-inverso-Tat nonapeptide and saquinavir demonstrate combined anti-HIV effects. AIDS Res Ther 2006;3:12
- Derossi D, Calvet S, Trembleau A, et al. Cell internalization of the third helix of the antennapedia homeodomain is receptor-independent. J Biol Chem 1996;271:18188-93
- Richard JP, Melikov K, Vives E, et al. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 2003;278:585-90
- Suzuki T, Futaki S, Niwa M, et al. Possible existence of common internalization mechanisms among arginine-rich peptides. J Biol Chem 2002;277:2437-43
- Duchardt F, Fotin-Mleczek M, Schwarz H, et al. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 2007;8:848-66
- Laakkonen P, Ruoslahti E. Selective delivery to vascular addresses: In vivo applications of cell-type-specific cell-penetrating peptides. In: Langel Ü, editor, Handbook of cell-penetrating peptides. CRC Press, Boca Raton 2007. p. 413-22
- Myrberg H, Zhang LL, Mae M, et al. Design of a tumor-homing cell-penetrating peptide. Bioconjugate Chem 2008;19:70-5
- Jiang T, Olson ES, Nguyen QT, et al. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci USA 2004;101:17867-72
- Sato AK, Viswanathan M, Kent RB, et al. Therapeutic peptides: technological advances driving peptides into development. Curr Opin Biotechnol 2006;17:638-42
- Gysin R, Wergedal JE, Sheng MHC, et al. Ex vivo gene therapy with stromal cells transduced with a retroviral vector containing the BMP4 gene completely heals critical size calvarial defects in rats. Gene Ther 2002;9:991-9